Literature DB >> 31018913

Oxandrolone protects against the development of multiorgan failure, modulates the systemic inflammatory response and promotes wound healing during burn injury.

Akbar Ahmad1, David N Herndon2, Csaba Szabo3.   

Abstract

Oxandrolone is a synthetic oral non-aromatizable testosterone derivative. This drug has been used successfully for several decades to safely treat growth delays in various diseases including Turner's syndrome. Currently the use of oxandrolone is under clinical testing in children with burn injury; the available data indicate that the anabolic steroid increases net muscle protein balance, maintains lean body mass, and reduces intensive care unit stay. Although oxandrolone is already in clinical trials in burn patients, preclinical burn-related studies with oxandrolone - especially those that go beyond muscle-related parameters and focus on burn-associated organ dysfunction, inflammatory response and wound healing - remain to be conducted. In the current project, using a well-characterized murine model of third-degree burn, we have tested the effect of oxandrolone on indices of organ injury, clinical chemistry parameters and plasma levels of inflammatory mediators. In oxandrolone-treated mice (1mg/kg/day for up to 21 days) there was a significant amelioration of burn-induced accumulation of myeloperoxidase levels in heart and lung (but not the liver and kidney) and significantly lower degree of malon dialdehyde accumulation in the liver (but not the heart, lung and kidney). Oxandrolone-treated mice showed a significant attenuation of the burn-induced elevation in circulating alkaline aminotransferase and amylase levels, while blood urea nitrogen and creatinine levels remained unaffected, indicative of protective effects of the anabolic hormone against burn-induced hepatic and pancreatic (but not renal) functional impairment. Multiple burn-induced inflammatory mediators (TNF-α, IL-1α, IL-1β, IL-4, IL-6, IL-10, IL-12, IP-10, G-CSF, GM-CSF and interferon-γ) were significantly lower in the plasma of oxandrolone-treated animals after burn injury than in the plasma of controls subjected to burns. Finally, oxandrolone significantly accelerated burn wound healing. We conclude that oxandrolone improves organ function, modulates the systemic inflammatory response and accelerates wound healing in a murine model of burn injury.
Copyright © 2018 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Anabolic steroids; Angiogenesis; Burns; Inflammation; Oxidative stress

Year:  2018        PMID: 31018913     DOI: 10.1016/j.burns.2018.10.006

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  4 in total

Review 1.  Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence.

Authors:  Eri Shirakami; Sho Yamakawa; Kenji Hayashida
Journal:  Burns Trauma       Date:  2020-01-27

2.  Induced sputum metabolomic profiles and oxidative stress are associated with chronic obstructive pulmonary disease (COPD) severity: potential use for predictive, preventive, and personalized medicine.

Authors:  Tao Zhu; Shanqun Li; Jiajia Wang; Chunfang Liu; Lei Gao; Yuzhen Zeng; Ruolin Mao; Bo Cui; Hong Ji; Zhihong Chen
Journal:  EPMA J       Date:  2020-11-04       Impact factor: 6.543

3.  A Screening Tool to Detect Chronic Critically Ill Cardiac Surgery Patients at Risk for Low Levels of Testosterone and Somatomedin C: A Prospective Observational Pilot Study.

Authors:  Ceressa T Ward; David W Boorman; Ava Afshar; Amit Prabhakar; Babar Fiza; Laura R Pyronneau; Amber Kimathi; Carmen Paul; Berthold Moser; Vanessa Moll
Journal:  Cureus       Date:  2021-05-28

4.  Cutaneous Thermal Injury Modulates Blood and Skin Metabolomes Differently in a Murine Model.

Authors:  Abdulnaser Alkhalil; Robert L Ball; Gaurav Garg; Anna Day; Bonnie C Carney; Raina Kumar; Rasha Hammamieh; Lauren T Moffatt; Jeffrey W Shupp
Journal:  J Burn Care Res       Date:  2021-08-04       Impact factor: 1.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.